草药药物的监管和标准化:目前的状态,限制,挑战和未来的前景
1Faculty of Medicine, Ciputra University, Surabaya, Indonesia.
Profiles of drug substances, excipients, and related methodology
|February 29, 2024
概括
草药 (HD) 的质量评估由于其复杂性而具有挑战性. 本综述比较了全球法规和标准化方法,以确保这些广泛使用的传统药物的安全性和有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传统医学的传统医学.
- 质量控制 质量控制 质量控制
背景情况:
- 草药 (HD) 在全球广泛使用,具有显著的市场价值.
- 确保HD的安全性和有效性至关重要,需要监管监督.
- 霍乱病毒复杂的化学成分对质量评估提出了挑战.
研究的目的:
- 对草药药物的国际法规进行审查和比较.
- 讨论评估高清质量的标准化方法.
- 确定高清质量控制的局限性和未来前景.
主要方法:
- 对美国,欧盟,日本,台湾,香港和印度尼西亚的法规进行比较分析.
- 审查当前的官方标准化方法及其局限性.
- 讨论评估混合草药和制剂所面临的挑战.
主要成果:
- 官方的综合方法往往不足以评估复杂的HD配方.
- 高强度的生产者需要开发和验证特定的质量评估方法.
- 原材料来源的变化会影响高清质量.
结论:
- 标准化HD需要的方法可以处理复杂的混合物.
- 未来的方法应该是最先进的,快速的,具有成本效益的,准确的和精确的.
- 需要协调的方法来对草药进行可靠的全球质量评估.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Drug Classes and Categories
2.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K
Drug Nomenclature
1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833


